Related Experiment Video
Updated: Apr 24, 2026

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
Published on: December 23, 2025
Artificial intelligence chatbots and idiopathic pulmonary fibrosis: are they ready to inform patients?
Merve Yumrukuz Şenel1, Emine Ayan1, Mustafa Çolak1
1Balıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.
Objective:
The aim of this study was to determine the quality, reliability, and readability of the responses provided by artificial intelligence chatbots about idiopathic pulmonary fibrosis.
Methods:
The clinically relevant questions about idiopathic pulmonary fibrosis diagnosis, treatment, prognosis, and lifestyle management were submitted to four widely used artificial intelligence chatbots, including ChatGPT, Perplexity, Gemini, and Copilot. Responses were assessed by five clinicians based on readability, understandability, quality, and content reliability using standardized tools.
Results:
The overall readability of chatbot-generated responses was low, corresponding to high educational requirements. Understandability ranged from moderate to good, whereas actionability remained moderate. Gemini produced the most readable and understandable outputs. Journal of the American Medical Association and Likert scores indicated limited source transparency but good guideline concordance. DISCERN analysis for the treatment question showed significant variation (p=0.003), with Perplexity achieving the highest total score.
Conclusion:
Although artificial intelligence chatbots offer rapid and accessible information, their readability and source reliability remain limited. These findings highlight the necessity of expert supervision and further model improvement before artificial intelligence chatbots can be safely integrated into patient education.
Related Concept Videos
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
EPS and iPS Cells in Disease Research
Non-equilibrium in the Cell
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

